Selective microglial activation in the rat rotenone model of Parkinson's disease
- 25 March 2003
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 341 (2) , 87-90
- https://doi.org/10.1016/s0304-3940(03)00172-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein AggregationExperimental Neurology, 2003
- Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in ratsBehavioural Brain Research, 2002
- Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson DiseaseJournal of Neuroscience, 2002
- Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic NeuronsJournal of Neuroscience, 2002
- Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's diseaseProceedings of the National Academy of Sciences, 2001
- Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatumBrain Research, 2001
- Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brainNeuroscience, 1990
- Abnormalities of the electron transport chain in idiopathic parkinson's diseaseAnnals of Neurology, 1989
- Deficiencies in Complex I subunits of the respiratory chain in Parkinson's diseaseBiochemical and Biophysical Research Communications, 1989
- MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASEPublished by Elsevier ,1989